Admission Glucose Level Predicts In-hospital Mortality in Patients with Acute Pulmonary Embolism Who Were Treated with Thrombolytic Therapy


Bozbay M., Uyarel H., Avsar S., Oz A., Keskin M., Murat A., ...Daha Fazla

LUNG, cilt.194, sa.2, ss.219-226, 2016 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 194 Sayı: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1007/s00408-016-9858-3
  • Dergi Adı: LUNG
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.219-226
  • Anahtar Kelimeler: Pulmonary embolism, Glucose, Thrombolytic therapy, Mortality, Clinical outcomes, HYPERGLYCEMIA PREDICTS, DIABETES-MELLITUS, EUROPEAN-SOCIETY, STROKE PATIENTS, HEART-FAILURE, TASK-FORCE, DIAGNOSIS, GUIDELINES, METAANALYSIS, MANAGEMENT
  • Marmara Üniversitesi Adresli: Evet

Özet

Elevated admission serum glucose level is associated with unfavourable clinical outcomes in various clinical conditions. The aim of this study was to investigate the relationship between admission glucose levels and in-hospital and long-term adverse clinical outcomes in patients with pulmonary embolism (PE) treated with thrombolytic therapy.